1989
DOI: 10.1021/ja00198a068
|View full text |Cite
|
Sign up to set email alerts
|

Interstrand DNA cross-linking with dimers of the spirocyclopropyl alkylating moiety of CC-1065

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

1996
1996
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…To reduce the side effects and to increase selectivity, many new types of crosslinking agents have been investigated extensively . A member of the cyclopropapyrroloindole (CPI) family, bizelesin (NSC‐615 291) is a bifunctional alkylating agent that contains two alkylating CPIs linked by a flexible methylene chain . Based on its preference for AT‐rich sequences and its antitumor activity, the National Cancer Institute has selected bizelesin as a potential chemotherapeutic agent .…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…To reduce the side effects and to increase selectivity, many new types of crosslinking agents have been investigated extensively . A member of the cyclopropapyrroloindole (CPI) family, bizelesin (NSC‐615 291) is a bifunctional alkylating agent that contains two alkylating CPIs linked by a flexible methylene chain . Based on its preference for AT‐rich sequences and its antitumor activity, the National Cancer Institute has selected bizelesin as a potential chemotherapeutic agent .…”
Section: Methodsmentioning
confidence: 99%
“…[5] Am ember of the cyclopropapyrroloindole (CPI) family,b izelesin (NSC-615291)i sabifunctional alkylating agent that contains two alkylating CPIs linked by aflexible methylene chain. [6] Based on itsp reference for AT-rich sequences and its antitumora ctivity, [7] the National Cancer Institute has selected bizelesin as ap otential chemotherapeutic agent. [8] Compared with the CPI, the seco-CBI moiety has greater reactivity and selectivity toward DNA and is more stable in aqueous solution.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Molecules containing two CPI groups have been developed to achieve higher potency from intra-and interstrand DNA crosslinking (Mitchell et al, 1989;Boger et al, 2000). Most notably, bizelesin, a CPI-dimer, was evaluated in a phase I clinical trial for advanced solid tumors (Schwartz et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Most notably, bizelesin, a CPI-dimer, was evaluated in a phase I clinical trial for advanced solid tumors (Schwartz et al, 2003). Mitchell et al (1989) synthesized several CPI dimers and found an optimal chain length of three carbons with a 2-pM in vitro IC 50 . Jia and Lown (2000) also reported seco-CBI dimers linked with three carbons showing the highest in vitro potency.…”
Section: Introductionmentioning
confidence: 99%